Skip to main content

Advertisement

Peer Review reports

From: Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer

Original Submission
15 Apr 2009 Submitted Original manuscript
2 Jun 2009 Reviewed Reviewer Report - Reiki Nishimura
24 Jun 2009 Reviewed Reviewer Report - Shaheenah Dawood
20 Aug 2009 Author responded Author comments - Masakazu Toi
Resubmission - Version 2
20 Aug 2009 Submitted Manuscript version 2
21 Aug 2009 Reviewed Reviewer Report - Reiki Nishimura
8 Sep 2009 Reviewed Reviewer Report - Shaheenah Dawood
27 Oct 2009 Author responded Author comments - Masakazu Toi
Resubmission - Version 3
27 Oct 2009 Submitted Manuscript version 3
24 Dec 2009 Author responded Author comments - Masakazu Toi
Resubmission - Version 4
24 Dec 2009 Submitted Manuscript version 4
12 Jan 2010 Author responded Author comments - Masakazu Toi
Resubmission - Version 5
12 Jan 2010 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
22 Jan 2010 Author responded Author comments - Masakazu Toi
Resubmission - Version 7
22 Jan 2010 Submitted Manuscript version 7
Resubmission - Version 8
Submitted Manuscript version 8
Resubmission - Version 9
Submitted Manuscript version 9
28 Jan 2010 Author responded Author comments - Masakazu Toi
Resubmission - Version 10
28 Jan 2010 Submitted Manuscript version 10
Publishing
23 Feb 2010 Editorially accepted
23 Feb 2010 Article published 10.1186/1471-2407-10-56

You can find further information about peer review here.

Back to article page